Pyxis Oncology Reports Financial Results for the Second Quar

• Prioritized pipeline to focus on most advanced programs while maintaining financial flexibility to pursue business development opportunities • Appointed Rachel Humphrey, M.D., a... | August 15, 2022

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Jay Feingold , Legochem Biosciences , Courtney Dugan , Rachel Humphrey , Klara Sullivan , Head Of Investor Relations Corporate Communications , Corporate Development , Clinical Development At Bristol Myers Squibb , Pyxis Oncology Inc , Company Quarterly Report On Form , Globenewswire Inc , Nasdaq , Chief Executive Officer , Drug Conjugate , Investigational New Drug , Chief Medical Officer , Black Diamond Therapeutics , Cytomx Therapeutics , Vice President , Clinical Development , Bristol Myers Squibb , Quarter Ended , Common Stock , Private Securities Litigation Reform Act , Quarterly Report , Oncology Contact , Investor Relations , Corporate Communications , Consolidated Statements , Pyxis Oncology , Nc Stock Exchange , News , Information , Press Release , Prioritized , Pipeline , O , Focus , N , Most , Dvanced , Programs , Chile , Maintaining , Financial , Flexibility , Ursue , Business , Development , Opportunities , Appointed , Achel Pyxs Us7473241013 ,